When drugs are registered, relatively little is known about their adverse effects as clinical trials generally include only small numbers of patients and are of limited duration. New European legislation and the monitoring of adverse events are intended to enable the timely recognition of adverse effects of newly-registered drugs. However, many adverse… (More)
Figures and Tables
Sorry, we couldn't extract any figures or tables for this paper.